Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Antibody Drug Conjugates Market 2018, Forecast to 2023

January 2019 | 133 pages | ID: G06F8481163EN
GlobalInfoResearch

Abstracts

Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. 

Scope of the Report:

This report focuses on the Antibody Drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The worldwide market for Antibody Drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• F. Hoffman-La Roche
• Novartis AG
• Takeda Pharmaceutical
• Pfizer
• Seattle Genetics
• Genentech
• Immunogen
• Progenics Pharmaceuticals
• Bayer Healthcare Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Adcetris
• Kadcyla

Market Segment by Applications, can be divided into

• Breast Cancer
• Lymphoma

There are 15 Chapters to deeply display the global Antibody Drug Conjugates market.
Chapter 1, to describe Antibody Drug Conjugates Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antibody Drug Conjugates, with sales, revenue, and price of Antibody Drug Conjugates, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibody Drug Conjugates, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antibody Drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antibody Drug Conjugates sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Antibody Drug Conjugates Introduction
1.2 Market Analysis by Type
  1.2.1 Adcetris
  1.2.2 Kadcyla
1.3 Market Analysis by Applications
  1.3.1 Breast Cancer
  1.3.2 Lymphoma
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 F. Hoffman-La Roche
  2.1.1 Business Overview
    2.1.1.1 F. Hoffman-La Roche Description
    2.1.1.2 F. Hoffman-La Roche Headquarter, Main Business and Finance Overview
  2.1.2 F. Hoffman-La Roche Antibody Drug Conjugates Product Introduction
    2.1.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Antibody Drug Conjugates Product Information
  2.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global F. Hoffman-La Roche Antibody Drug Conjugates Market Share in 2017
2.2 Novartis AG
  2.2.1 Business Overview
    2.2.1.1 Novartis AG Description
    2.2.1.2 Novartis AG Headquarter, Main Business and Finance Overview
  2.2.2 Novartis AG Antibody Drug Conjugates Product Introduction
    2.2.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Antibody Drug Conjugates Product Information
  2.2.3 Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Novartis AG Antibody Drug Conjugates Market Share in 2017
2.3 Takeda Pharmaceutical
  2.3.1 Business Overview
    2.3.1.1 Takeda Pharmaceutical Description
    2.3.1.2 Takeda Pharmaceutical Headquarter, Main Business and Finance Overview
  2.3.2 Takeda Pharmaceutical Antibody Drug Conjugates Product Introduction
    2.3.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Antibody Drug Conjugates Product Information
  2.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Takeda Pharmaceutical Antibody Drug Conjugates Market Share in 2017
2.4 Pfizer
  2.4.1 Business Overview
    2.4.1.1 Pfizer Description
    2.4.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.4.2 Pfizer Antibody Drug Conjugates Product Introduction
    2.4.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Antibody Drug Conjugates Product Information
  2.4.3 Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Pfizer Antibody Drug Conjugates Market Share in 2017
2.5 Seattle Genetics
  2.5.1 Business Overview
    2.5.1.1 Seattle Genetics Description
    2.5.1.2 Seattle Genetics Headquarter, Main Business and Finance Overview
  2.5.2 Seattle Genetics Antibody Drug Conjugates Product Introduction
    2.5.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Antibody Drug Conjugates Product Information
  2.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Seattle Genetics Antibody Drug Conjugates Market Share in 2017
2.6 Genentech
  2.6.1 Business Overview
    2.6.1.1 Genentech Description
    2.6.1.2 Genentech Headquarter, Main Business and Finance Overview
  2.6.2 Genentech Antibody Drug Conjugates Product Introduction
    2.6.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Antibody Drug Conjugates Product Information
  2.6.3 Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Genentech Antibody Drug Conjugates Market Share in 2017
2.7 Immunogen
  2.7.1 Business Overview
    2.7.1.1 Immunogen Description
    2.7.1.2 Immunogen Headquarter, Main Business and Finance Overview
  2.7.2 Immunogen Antibody Drug Conjugates Product Introduction
    2.7.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Antibody Drug Conjugates Product Information
  2.7.3 Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Immunogen Antibody Drug Conjugates Market Share in 2017
2.8 Progenics Pharmaceuticals
  2.8.1 Business Overview
    2.8.1.1 Progenics Pharmaceuticals Description
    2.8.1.2 Progenics Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.8.2 Progenics Pharmaceuticals Antibody Drug Conjugates Product Introduction
    2.8.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Antibody Drug Conjugates Product Information
  2.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Progenics Pharmaceuticals Antibody Drug Conjugates Market Share in 2017
2.9 Bayer Healthcare Pharmaceuticals
  2.9.1 Business Overview
    2.9.1.1 Bayer Healthcare Pharmaceuticals Description
    2.9.1.2 Bayer Healthcare Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.9.2 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product Introduction
    2.9.2.1 Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Antibody Drug Conjugates Product Information
  2.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Market Share in 2017

3 GLOBAL ANTIBODY DRUG CONJUGATES MARKET COMPETITION, BY MANUFACTURER

3.1 Global Antibody Drug Conjugates Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antibody Drug Conjugates Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Antibody Drug Conjugates Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Antibody Drug Conjugates Manufacturer Market Share in 2017
  3.4.2 Top 5 Antibody Drug Conjugates Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY REGIONS

4.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Regions
  4.1.1 Global Antibody Drug Conjugates Sales by Regions (2013-2018)
  4.1.2 Global Antibody Drug Conjugates Revenue by Regions (2013-2018)
4.2 North America Antibody Drug Conjugates Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Antibody Drug Conjugates Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Antibody Drug Conjugates Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIBODY DRUG CONJUGATES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  5.1.1 North America Antibody Drug Conjugates Sales by Countries (2013-2018)
  5.1.2 North America Antibody Drug Conjugates Revenue by Countries (2013-2018)
  5.1.3 United States Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  5.1.4 Canada Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5.2 North America Antibody Drug Conjugates Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Antibody Drug Conjugates Sales by Manufacturers (2016-2017)
  5.2.2 North America Antibody Drug Conjugates Revenue by Manufacturers (2016-2017)
5.3 North America Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Antibody Drug Conjugates Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Antibody Drug Conjugates Revenue and Revenue Share by Type (2013-2018)
5.4 North America Antibody Drug Conjugates Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Antibody Drug Conjugates Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Antibody Drug Conjugates Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ANTIBODY DRUG CONJUGATES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antibody Drug Conjugates Sales by Countries (2013-2018)
  6.1.2 Europe Antibody Drug Conjugates Revenue by Countries (2013-2018)
  6.1.3 Germany Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  6.1.4 UK Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  6.1.5 France Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  6.1.6 Russia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  6.1.7 Italy Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.2 Europe Antibody Drug Conjugates Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Antibody Drug Conjugates Sales by Manufacturers (2016-2017)
  6.2.2 Europe Antibody Drug Conjugates Revenue by Manufacturers (2016-2017)
6.3 Europe Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Antibody Drug Conjugates Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Antibody Drug Conjugates Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Antibody Drug Conjugates Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Antibody Drug Conjugates Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Antibody Drug Conjugates Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ANTIBODY DRUG CONJUGATES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antibody Drug Conjugates Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Antibody Drug Conjugates Revenue by Countries (2013-2018)
  7.1.3 China Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  7.1.4 Japan Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  7.1.5 Korea Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  7.1.6 India Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Antibody Drug Conjugates Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Antibody Drug Conjugates Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Antibody Drug Conjugates Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Antibody Drug Conjugates Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Antibody Drug Conjugates Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Antibody Drug Conjugates Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Antibody Drug Conjugates Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ANTIBODY DRUG CONJUGATES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  8.1.1 South America Antibody Drug Conjugates Sales by Countries (2013-2018)
  8.1.2 South America Antibody Drug Conjugates Revenue by Countries (2013-2018)
  8.1.3 Brazil Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8.2 South America Antibody Drug Conjugates Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Antibody Drug Conjugates Sales by Manufacturers (2016-2017)
  8.2.2 South America Antibody Drug Conjugates Revenue by Manufacturers (2016-2017)
8.3 South America Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Antibody Drug Conjugates Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Antibody Drug Conjugates Revenue and Revenue Share by Type (2013-2018)
8.4 South America Antibody Drug Conjugates Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Antibody Drug Conjugates Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Antibody Drug Conjugates Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ANTIBODY DRUG CONJUGATES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antibody Drug Conjugates Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Antibody Drug Conjugates Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  9.1.4 UAE Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Antibody Drug Conjugates Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Antibody Drug Conjugates Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Antibody Drug Conjugates Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antibody Drug Conjugates Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antibody Drug Conjugates Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Antibody Drug Conjugates Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Antibody Drug Conjugates Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SEGMENT BY TYPE

10.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Antibody Drug Conjugates Sales and Market Share by Type (2013-2018)
  10.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2013-2018)
10.2 Adcetris Sales Growth and Price
  10.2.1 Global Adcetris Sales Growth (2013-2018)
  10.2.2 Global Adcetris Price (2013-2018)
10.3 Kadcyla Sales Growth and Price
  10.3.1 Global Kadcyla Sales Growth (2013-2018)
  10.3.2 Global Kadcyla Price (2013-2018)

11 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SEGMENT BY APPLICATION

11.1 Global Antibody Drug Conjugates Sales Market Share by Application (2013-2018)
11.2 Breast Cancer Sales Growth (2013-2018)
11.3 Lymphoma Sales Growth (2013-2018)

12 ANTIBODY DRUG CONJUGATES MARKET FORECAST (2018-2023)

12.1 Global Antibody Drug Conjugates Sales, Revenue and Growth Rate (2018-2023)
12.2 Antibody Drug Conjugates Market Forecast by Regions (2018-2023)
  12.2.1 North America Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.2 Europe Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.4 South America Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Antibody Drug Conjugates Market Forecast (2018-2023)
12.3 Antibody Drug Conjugates Market Forecast by Type (2018-2023)
  12.3.1 Global Antibody Drug Conjugates Sales Forecast by Type (2018-2023)
  12.3.2 Global Antibody Drug Conjugates Market Share Forecast by Type (2018-2023)
12.4 Antibody Drug Conjugates Market Forecast by Application (2018-2023)
  12.4.1 Global Antibody Drug Conjugates Sales Forecast by Application (2018-2023)
  12.4.2 Global Antibody Drug Conjugates Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antibody Drug Conjugates Picture
Table Product Specifications of Antibody Drug Conjugates
Figure Global Antibody Drug Conjugates CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Antibody Drug Conjugates CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Antibody Drug Conjugates by Types in 2017
Figure Adcetris Picture
Table Major Manufacturers of Adcetris
Figure Kadcyla Picture
Table Major Manufacturers of Kadcyla
Figure Antibody Drug Conjugates Sales Market Share by Applications in 2017
Figure Breast Cancer Picture
Figure Lymphoma Picture
Figure United States Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure France Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure China Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure India Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Table F. Hoffman-La Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table F. Hoffman-La Roche Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table F. Hoffman-La Roche Antibody Drug Conjugates Product
Table F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F. Hoffman-La Roche Antibody Drug Conjugates Sales Market Share in 2017
Figure Global F. Hoffman-La Roche Antibody Drug Conjugates Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Novartis AG Antibody Drug Conjugates Product
Table Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Novartis AG Antibody Drug Conjugates Revenue Market Share in 2017
Table Takeda Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Pharmaceutical Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Takeda Pharmaceutical Antibody Drug Conjugates Product
Table Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Pharmaceutical Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Takeda Pharmaceutical Antibody Drug Conjugates Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Pfizer Antibody Drug Conjugates Product
Table Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Pfizer Antibody Drug Conjugates Revenue Market Share in 2017
Table Seattle Genetics Headquarter, Established, Main Business and Finance Overview (2017)
Table Seattle Genetics Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Seattle Genetics Antibody Drug Conjugates Product
Table Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Seattle Genetics Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Seattle Genetics Antibody Drug Conjugates Revenue Market Share in 2017
Table Genentech Headquarter, Established, Main Business and Finance Overview (2017)
Table Genentech Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Genentech Antibody Drug Conjugates Product
Table Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genentech Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Genentech Antibody Drug Conjugates Revenue Market Share in 2017
Table Immunogen Headquarter, Established, Main Business and Finance Overview (2017)
Table Immunogen Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Immunogen Antibody Drug Conjugates Product
Table Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Immunogen Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Immunogen Antibody Drug Conjugates Revenue Market Share in 2017
Table Progenics Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Progenics Pharmaceuticals Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Progenics Pharmaceuticals Antibody Drug Conjugates Product
Table Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Progenics Pharmaceuticals Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Progenics Pharmaceuticals Antibody Drug Conjugates Revenue Market Share in 2017
Table Bayer Healthcare Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production Bases, Sales Regions and Major Competitors
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales Market Share in 2017
Figure Global Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Revenue Market Share in 2017
Table Global Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure Global Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure Global Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table Global Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table Global Antibody Drug Conjugates Price by Manufacturer (2016-2017)
Figure Top 3 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2017
Figure Global Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Global Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Global Antibody Drug Conjugates Sales by Regions (2013-2018)
Table Global Antibody Drug Conjugates Sales Market Share by Regions (2013-2018)
Table Global Antibody Drug Conjugates Revenue by Regions (2013-2018)
Figure Global Antibody Drug Conjugates Revenue Market Share by Regions in 2013
Figure Global Antibody Drug Conjugates Revenue Market Share by Regions in 2017
Figure North America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure North America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Figure South America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure South America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Figure North America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table North America Antibody Drug Conjugates Sales by Countries (2013-2018)
Table North America Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure North America Antibody Drug Conjugates Sales Market Share by Countries in 2013
Figure North America Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table North America Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table North America Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure North America Antibody Drug Conjugates Revenue Market Share by Countries in 2013
Figure North America Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure United States Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Canada Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Mexico Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table North America Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure North America Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure North America Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table North America Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure North America Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure North America Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table North America Antibody Drug Conjugates Sales by Type (2013-2018)
Table North America Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table North America Antibody Drug Conjugates Revenue by Type (2013-2018)
Table North America Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Table North America Antibody Drug Conjugates Sales by Application (2013-2018)
Table North America Antibody Drug Conjugates Sales Share by Application (2013-2018)
Table North America Antibody Drug Conjugates Revenue by Application (2013-2018)
Table North America Antibody Drug Conjugates Revenue Share by Application (2013-2018)
Figure Europe Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Europe Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Europe Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Table Europe Antibody Drug Conjugates Revenue by Countries (2013-2018)
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries in 2016
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Germany Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure UK Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure France Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Russia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Italy Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table Europe Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure Europe Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure Europe Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table Europe Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure Europe Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure Europe Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table Europe Antibody Drug Conjugates Sales by Type (2013-2018)
Table Europe Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table Europe Antibody Drug Conjugates Revenue by Type (2013-2018)
Table Europe Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Table Europe Antibody Drug Conjugates Sales by Application (2013-2018)
Table Europe Antibody Drug Conjugates Sales Share by Application (2013-2018)
Table Europe Antibody Drug Conjugates Revenue by Application (2013-2018)
Table Europe Antibody Drug Conjugates Revenue Share by Application (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Countries 2017
Table Asia-Pacific Antibody Drug Conjugates Revenue by Countries (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Countries 2017
Figure China Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Japan Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Korea Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure India Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Antibody Drug Conjugates Sales by Type (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Revenue by Type (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales by Application (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales Share by Application (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Revenue by Application (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Revenue Share by Application (2013-2018)
Figure South America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table South America Antibody Drug Conjugates Sales by Countries (2013-2018)
Table South America Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure South America Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table South America Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table South America Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure South America Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Brazil Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Argentina Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Colombia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table South America Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure South America Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure South America Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table South America Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure South America Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure South America Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table South America Antibody Drug Conjugates Sales by Type (2013-2018)
Table South America Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table South America Antibody Drug Conjugates Revenue by Type (2013-2018)
Table South America Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Table South America Antibody Drug Conjugates Sales by Application (2013-2018)
Table South America Antibody Drug Conjugates Sales Share by Application (2013-2018)
Table South America Antibody Drug Conjugates Revenue by Application (2013-2018)
Table South America Antibody Drug Conjugates Revenue Share by Application (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table Middle East and Africa Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure UAE Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Egypt Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Nigeria Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure South Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Antibody Drug Conjugates Sales by Type (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue by Type (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales by Application (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales Share by Application (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue by Application (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue Share by Application (2013-2018)
Table Global Antibody Drug Conjugates Sales by Type (2013-2018)
Table Global Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table Global Antibody Drug Conjugates Revenue by Type (2013-2018)
Table Global Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Figure Global Adcetris Sales Growth (2013-2018)
Figure Global Adcetris Price (2013-2018)
Figure Global Kadcyla Sales Growth (2013-2018)
Figure Global Kadcyla Price (2013-2018)
Table Global Antibody Drug Conjugates Sales by Application (2013-2018)
Table Global Antibody Drug Conjugates Sales Share by Application (2013-2018)
Figure Global Breast Cancer Sales Growth (2013-2018)
Figure Global Lymphoma Sales Growth (2013-2018)
Figure Global Antibody Drug Conjugates Sales, Revenue and Growth Rate (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Regions (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Europe Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure South America Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Type (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Type (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Application (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List